Abbott | ABT - Umsatzerlöse

Aktienkurs
105.56
Täglich Wechseln
-1.63 -1.52%
Monatlich
-8.44%
Jährlich
-16.45%
Q1 Prognose
104.77




Der Umsatz Veränderung Datum
Abbott USD 11.46B 90M 2025-12
Agilent USD 1.8B 63M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Cooper Companies USD 1.02B 41.1M 2025-12
Danaher USD 6.84B 790M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Globus Medical USD 826.4M 57.4M 2025-12
Hologic USD 1.05B 0 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
J&J USD 24.6B 610M 2025-12
Masimo USD 412.5M 41M 2025-12
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 393.9M 9.7M 2025-12
Pfizer USD 17.58B 880M 2025-12
Smith & Nephew USD 3.18B 353M 2025-12
Solventum Corp USD 1.99B 110M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Zimmer Biomet Holdings USD 2.24B 240M 2025-12